27.06.2011
- DSM has appointed Marcel Wubbolts, currently vice president R&D DSM Innovation Center, to the position of chief technology officer as of Oct.1, reporting to Rob van Leen, Chief...
14.06.2011
- Biotech deals in the $1 billion to $5 billion range are likely to be a sweet spot for drug companies looking to bolster their pipelines through M&A in an increasingly tough...
07.06.2011
- Actelion, Europe's largest biotech company which has been under pressure from activist investor Elliott Advisors, is changing its management structure, including appointing a chief...
30.05.2011
- Doubled-Edged Sword - The emergence of biosimilars has caused very large ripples in the biopharma pond, and has recently been called the most "disruptive technology" of the decade...
30.05.2011
- Analysis - When comparing the fine chemicals market of today to that of 2001, a few clear differences can be seen. Fine chemicals expert Jan Ramakers takes an in-depth look at the...
30.05.2011
- Catalyst for Growth - With the chemical industry posting phenomenal Q1 numbers, it's clear that the worst of the economic crisis is over. The same goes for chemical distributors in...
12.05.2011
- Japan's largest drugmaker Takeda Pharmaceutical is in talks to buy privately-held Swiss rival Nycomed in a deal that could be valued at about $14.2 billion, Bloomberg said, citing...
11.05.2011
- It was a most unusual road trip - Drivers on the highways of Europe were probably surprised to see the scaled-down equivalent of a bioprocessing production line rolling next to...
11.05.2011
- Boom Region - In 2011, the markets for bio-based materials are continuing to develop dynamically (with annual growth rates of 15-30 %). It is estimated that a global production...
04.05.2011
- Europe's largest biotech Actelion was dealt a blow when a jury in a Californian court said Japanese drugmaker Asahi Kasei should be awarded up to $547 million in a licensing...
